10/30/2025
The Ohio State University College of Pharmacy and OSUCCC-James Cancer Hospital and Solove Research Institute have been awarded a five-year, $7 million competitive Program Project Grant (PPG) renewal from the National Cancer Institute (NCI).
The grant renewal is led by Contact Principal Investigator A. Douglas Kinghorn, PhD, BS Pharm, DSc, FRPharmS, professor and Jack L. Beal Chair of the Division of Medicinal Chemistry and Pharmacognosy at the College of Pharmacy.
This renewal, for years 16-20, will continue to support the college’s longest-funded research project and its only active P01 grant. It remains the only NCI-funded PPG in the nation led by a pharmacy investigator.
It will allow teams at The Ohio State University, University of Illinois Chicago and UNC Greensboro to continue investigating potential anticancer drug leads based on compounds from tropical plants, U.S. coastal lichens, cultured terrestrial cyanobacteria and filamentous fungi.
Read more at
Dr. A. Douglas Kinghorn leads $7 million NCI grant renewal for cancer drug discovery research October 24, 2025 The Ohio State University College of Pharmacy and Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) have been award...